Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Junichi Inokuchi"'
Autor:
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Publikováno v:
Asian Journal of Urology, Vol 10, Iss 1, Pp 81-88 (2023)
Objective: There are many models to predict extracapsular extension (ECE) in patients with prostate cancer. We aimed to externally validate several models in a Japanese cohort. Methods: We included patients treated with robotic-assisted radical prost
Externí odkaz:
https://doaj.org/article/413df8fe86c246838d5aa77174dc0391
Autor:
Shigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, Shohei Nagakawa, Takashi Matsumoto, Ryo Kiyokoba, Mikako Yagi, Daiki Setoyama, Nozomi Noda, Shinya Matsumoto, Tetsutaro Hayashi, Alberto Contreras-Sanz, Peter C. Black, Junichi Inokuchi, Kenichi Kohashi, Yoshinao Oda, Takeshi Uchiumi, Masatoshi Eto, Dongchon Kang
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Chemotherapy is a standard therapy for muscle-invasive bladder cancer (MIBC). However, genomic alterations associated with chemotherapy sensitivity in MIBC have not been fully explored. This study aimed to investigate the genomic landscape o
Externí odkaz:
https://doaj.org/article/592f640d5f66404789c46f9398fa543d
Autor:
Shigetomo Yamada, Masaki Shiota, Leandro Blas, Takashi Matsumoto, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Ken-ichiro Shiga, Akira Yokomizo, Masatoshi Eto
Publikováno v:
Prostate International, Vol 10, Iss 1, Pp 50-55 (2022)
Background: Androgen receptor pathway inhibitors (ARPIs) such as abiraterone and enzalutamide have been shown to prolong survival in patients with advanced prostate cancer. However, there is limited evidence on the anticancer effect of a reduced dose
Externí odkaz:
https://doaj.org/article/bf0c9b5ed77f474e89a68a8d22bbbe84
Autor:
Sotaro Chikamatsu, Masaki Shiota, Shigetomo Yamada, Leandro Blas, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Ken-ichiro Shiga, Akira Yokomizo, Masatoshi Eto
Publikováno v:
Prostate International, Vol 10, Iss 1, Pp 7-13 (2022)
Background: The CHAARTED and LATITUDE trials demonstrated a survival benefit of docetaxel and abiraterone for hormone-sensitive prostate cancer. In this study, we examined the impact of the risk stratification criteria used in the CHAARTED and LATITU
Externí odkaz:
https://doaj.org/article/8610c69ac79a467c98ae471751c6ee74
Autor:
Ken Lee, Ryosuke Takahashi, Kenjiro Imada, Ayami Okabe, Shunichi Kajioka, Eiji Kashiwagi, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto
Publikováno v:
Continence, Vol 4, Iss , Pp 100516- (2022)
Introduction:: The objective of this study was to investigate the efficacy of the β3-adrenoreceptor agonist vibegron for the treatment of neurogenic lower urinary tract storage dysfunction in patients with spinal cord injury (SCI). Materials and Met
Externí odkaz:
https://doaj.org/article/82e087001a764b20bf1cf39ecdd508d6
Autor:
Katsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, Kensuke Hikami, Takeshi Yamada, Kosuke Ogawa, Kenji Nakamura, Naoto Sassa, Akira Yokomizo, Takashige Abe, Kazunari Tsuchihashi, Shuichi Tatarano, Junichi Inokuchi, Ryotaro Tomida, Maki Fujiwara, Atsushi Takahashi, Kazumasa Matsumoto, Kosuke Shimizu, Hiromasa Araki, Ryoma Kurahashi, Yu Osaki, Yu Tashiro, Masayuki Uegaki, Osamu Ogawa, Hiroshi Kitamura, Hiroyuki Nishiyama
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3188-3196 (2021)
Abstract Background The benefits of pembrolizumab in patients with advanced urothelial carcinoma (UC) and impaired performance status (PS) remain unknown. This study assessed the safety and efficacy of pembrolizumab in patients with platinum‐refrac
Externí odkaz:
https://doaj.org/article/98ad661f861345338f17b09eccbd721b
Autor:
Makito Miyake, Kota Iida, Nobutaka Nishimura, Tatsuki Miyamoto, Kiyohide Fujimoto, Ryotaro Tomida, Kazumasa Matsumoto, Kazuyuki Numakura, Junichi Inokuchi, Shuichi Morizane, Takahiro Yoneyama, Yoshiaki Matsumura, Takashige Abe, Masaharu Inoue, Takeshi Yamada, Naoki Terada, Shuya Hirao, Motohide Uemura, Yuto Matsushita, Rikiya Taoka, Takashi Kobayashi, Takahiro Kojima, Yoshiyuki Matsui, Hiroshi Kitamura, Hiroyuki Nishiyama, on behalf of the Japanese Urological Oncology Group
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background To explore possible solutions to overcome chronic Bacillus Calmette–Guérin (BCG) shortage affecting seriously the management of non-muscle invasive bladder cancer (NMIBC) in Europe and throughout the world, we investigated whet
Externí odkaz:
https://doaj.org/article/963b2cfef35b43e684b9694fc0587ca0
Autor:
Eiji Kashiwagi, Masaki Shiota, Hiroyuki Masaoka, Kenjiro Imada, Keisuke Monji, Ario Takeuchi, Junichi Inokuchi, Katsunori Tatsugami, Masatoshi Eto
Publikováno v:
Prostate International, Vol 8, Iss 1, Pp 22-26 (2020)
Background: To evaluate the relationship between body composition and the oncological outcome of androgen deprivation therapy (ADT), we investigated whether body composition features including the psoas muscle may be predictive factors of ADT. Method
Externí odkaz:
https://doaj.org/article/873cb7940c6b48d6b8e32324324eec59
Autor:
Yu Hirata, Masaki Shiota, Takeshi Kobayashi, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Katsunori Tatsugami, Masatoshi Eto
Publikováno v:
Prostate International, Vol 7, Iss 4, Pp 166-170 (2019)
Objective: The outcome of the androgen-deprivation therapy (ADT) may be affected by metabolic diseases such as diabetes mellitus (DM) and dyslipidemia and/or by their treatments. We aimed to evaluate the prognostic impact of these disorders and corre
Externí odkaz:
https://doaj.org/article/680b6a0d456d4db3b696b4f5b3901c32
Autor:
Masaki Shiota, Naohiro Fujimoto, Takashi Matsumoto, Shigehiro Tsukahara, Shohei Nagakawa, Shohei Ueda, Miho Ushijima, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Takeshi Uchiumi, Masatoshi Eto
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Transforming growth factor-β1 (TGF-β1) plays a dual role in cancer, acting as a tumor suppressor in the early stage of cancer development and as a tumor promoter in the later stage of cancer progression in various cancers. In this study, we investi
Externí odkaz:
https://doaj.org/article/a93856b498c54c75b3be08373029e4a7